![Autism And Cbd: What Science Says About Hemp Therapy [FItVIfuYe3z]](https://i0.wp.com/cedclinic.com/wp-content/uploads/2026/09/ced-pexels-13091435.jpg?resize=150%2C150&ssl=1 "Autism And Cbd: What Science Says About Hemp Therapy [FItVIfuYe3z] 2")
Large Canadian Study Documents How Older Adults Use Medical Cannabis — But Cannot Prove It Works
A large Canadian study on medical cannabis older adults Canada reports that most seniors using CBD-rich oils perceive improvements in pain, sleep, and mood. However, the absence of a control group means these benefits cannot be conclusively attributed to…
Older Adults Using Cannabis for Sleep Differ in Patterns From Other Cannabis Users, Small Clinic Survey Finds
Among cannabis users in our sample, 29% reported cannabis sleep disturbance older adults as their reason for use. These users showed higher frequency and preference for THC products compared to others. This survey provides preliminary insights into…
Older Adults with COPD Were Prescribed Synthetic Cannabinoids More Often—and at Higher Doses—Than Those Without the Disease
Synthetic oral cannabinoid prescribing is significantly more common among older adults with COPD compared to those without the disease. These patients also receive higher doses and longer treatment durations. Understanding these prescribing patterns is…
Nearly Half of Older Cancer Survivors Have Used Cannabis, But Fewer Than 1 in 10 Discussed It With Their Doctor
Cannabis use older cancer survivors is common, with nearly half reporting lifetime use. Despite this, fewer than 1 in 10 discuss their cannabis use with healthcare providers. This gap poses challenges for safe symptom management in older adults with…
Where Teens Get Misused Prescription Drugs Shapes Their Risk Profile
Nonmedical prescription drug misuse adolescents show varied risk profiles based on how they obtain drugs. Teens using multiple sources face higher substance use involvement. Understanding these patterns helps target prevention and screening.
Cannabis-Based Spray Shows Early Safety Promise for Alzheimer’s Agitation—But Proof of Efficacy Still Awaited
The nabiximols oromucosal spray feasibility trial demonstrated safe administration in Alzheimer's patients with agitation. Despite challenges, the study showed full adherence and no adverse reactions. These findings support larger trials to evaluate…
Drugs Detected in Suspected Pediatric Exposures: A 5-Year Review
This 5-year review focuses on pediatric cannabis exposure detection in suspected toxic ingestions. Comprehensive toxicology testing reveals cannabis metabolites as common findings. The study emphasizes the need for thorough screening in pediatric…
Evaluating Cannabis Substitution for Alcohol in a Canadian MAP
Cannabis substitution alcohol harm reduction is being evaluated within Canadian managed alcohol programs. This approach offers a potential lower-risk alternative for individuals with severe alcohol use disorder. The study provides early evidence…
Trends from the Rhode Island Harm Reduction Surveillance System: 2021-2024
This report highlights harm reduction polysubstance use disability trends in Rhode Island from 2021-2024. Cannabis use is prevalent among high-risk populations with disabilities. Understanding these patterns is critical for effective clinical…
Changes in Levels of Endocannabinoidome Mediators in Mice with Cancer Cachexia
Cancer cachexia involves significant changes in the endocannabinoid system cancer cachexia mediators, affecting metabolism and gut health. This study in mice reveals links between these mediators and steatosis as well as gut microbial dysbiosis.…